<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2024-10-02" version="227" xmlns="http://uniprot.org/uniprot">
  <accession>O60563</accession>
  <accession>A9XU13</accession>
  <accession>E7EX76</accession>
  <accession>O60581</accession>
  <name>CCNT1_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="24">Cyclin-T1</fullName>
      <shortName evidence="24">CycT1</shortName>
      <shortName>Cyclin-T</shortName>
    </recommendedName>
  </protein>
  <gene>
    <name type="primary">CCNT1</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1998" name="Cell" volume="92" first="451" last="462">
      <title>A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.</title>
      <authorList>
        <person name="Wei P."/>
        <person name="Garber M.E."/>
        <person name="Fang S.-M."/>
        <person name="Fischer W.H."/>
        <person name="Jones K.A."/>
      </authorList>
      <dbReference type="PubMed" id="9491887"/>
      <dbReference type="DOI" id="10.1016/s0092-8674(00)80939-3"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>PARTIAL PROTEIN SEQUENCE</scope>
    <scope>INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION)</scope>
    <source>
      <tissue>T-cell lymphoma</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1998" name="Genes Dev." volume="12" first="755" last="762">
      <title>Identification of multiple cyclin subunits of human P-TEFb.</title>
      <authorList>
        <person name="Peng J.-M."/>
        <person name="Zhu Y."/>
        <person name="Milton J.T."/>
        <person name="Price D.H."/>
      </authorList>
      <dbReference type="PubMed" id="9499409"/>
      <dbReference type="DOI" id="10.1101/gad.12.5.755"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <scope>IDENTIFICATION IN THE P-TEFB COMPLEX</scope>
    <source>
      <tissue>Mammary cancer</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="submission" date="2007-06" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Wu X."/>
        <person name="Liu Q."/>
        <person name="Guo D."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2006" name="Nature" volume="440" first="346" last="351">
      <title>The finished DNA sequence of human chromosome 12.</title>
      <authorList>
        <person name="Scherer S.E."/>
        <person name="Muzny D.M."/>
        <person name="Buhay C.J."/>
        <person name="Chen R."/>
        <person name="Cree A."/>
        <person name="Ding Y."/>
        <person name="Dugan-Rocha S."/>
        <person name="Gill R."/>
        <person name="Gunaratne P."/>
        <person name="Harris R.A."/>
        <person name="Hawes A.C."/>
        <person name="Hernandez J."/>
        <person name="Hodgson A.V."/>
        <person name="Hume J."/>
        <person name="Jackson A."/>
        <person name="Khan Z.M."/>
        <person name="Kovar-Smith C."/>
        <person name="Lewis L.R."/>
        <person name="Lozado R.J."/>
        <person name="Metzker M.L."/>
        <person name="Milosavljevic A."/>
        <person name="Miner G.R."/>
        <person name="Montgomery K.T."/>
        <person name="Morgan M.B."/>
        <person name="Nazareth L.V."/>
        <person name="Scott G."/>
        <person name="Sodergren E."/>
        <person name="Song X.-Z."/>
        <person name="Steffen D."/>
        <person name="Lovering R.C."/>
        <person name="Wheeler D.A."/>
        <person name="Worley K.C."/>
        <person name="Yuan Y."/>
        <person name="Zhang Z."/>
        <person name="Adams C.Q."/>
        <person name="Ansari-Lari M.A."/>
        <person name="Ayele M."/>
        <person name="Brown M.J."/>
        <person name="Chen G."/>
        <person name="Chen Z."/>
        <person name="Clerc-Blankenburg K.P."/>
        <person name="Davis C."/>
        <person name="Delgado O."/>
        <person name="Dinh H.H."/>
        <person name="Draper H."/>
        <person name="Gonzalez-Garay M.L."/>
        <person name="Havlak P."/>
        <person name="Jackson L.R."/>
        <person name="Jacob L.S."/>
        <person name="Kelly S.H."/>
        <person name="Li L."/>
        <person name="Li Z."/>
        <person name="Liu J."/>
        <person name="Liu W."/>
        <person name="Lu J."/>
        <person name="Maheshwari M."/>
        <person name="Nguyen B.-V."/>
        <person name="Okwuonu G.O."/>
        <person name="Pasternak S."/>
        <person name="Perez L.M."/>
        <person name="Plopper F.J.H."/>
        <person name="Santibanez J."/>
        <person name="Shen H."/>
        <person name="Tabor P.E."/>
        <person name="Verduzco D."/>
        <person name="Waldron L."/>
        <person name="Wang Q."/>
        <person name="Williams G.A."/>
        <person name="Zhang J."/>
        <person name="Zhou J."/>
        <person name="Allen C.C."/>
        <person name="Amin A.G."/>
        <person name="Anyalebechi V."/>
        <person name="Bailey M."/>
        <person name="Barbaria J.A."/>
        <person name="Bimage K.E."/>
        <person name="Bryant N.P."/>
        <person name="Burch P.E."/>
        <person name="Burkett C.E."/>
        <person name="Burrell K.L."/>
        <person name="Calderon E."/>
        <person name="Cardenas V."/>
        <person name="Carter K."/>
        <person name="Casias K."/>
        <person name="Cavazos I."/>
        <person name="Cavazos S.R."/>
        <person name="Ceasar H."/>
        <person name="Chacko J."/>
        <person name="Chan S.N."/>
        <person name="Chavez D."/>
        <person name="Christopoulos C."/>
        <person name="Chu J."/>
        <person name="Cockrell R."/>
        <person name="Cox C.D."/>
        <person name="Dang M."/>
        <person name="Dathorne S.R."/>
        <person name="David R."/>
        <person name="Davis C.M."/>
        <person name="Davy-Carroll L."/>
        <person name="Deshazo D.R."/>
        <person name="Donlin J.E."/>
        <person name="D'Souza L."/>
        <person name="Eaves K.A."/>
        <person name="Egan A."/>
        <person name="Emery-Cohen A.J."/>
        <person name="Escotto M."/>
        <person name="Flagg N."/>
        <person name="Forbes L.D."/>
        <person name="Gabisi A.M."/>
        <person name="Garza M."/>
        <person name="Hamilton C."/>
        <person name="Henderson N."/>
        <person name="Hernandez O."/>
        <person name="Hines S."/>
        <person name="Hogues M.E."/>
        <person name="Huang M."/>
        <person name="Idlebird D.G."/>
        <person name="Johnson R."/>
        <person name="Jolivet A."/>
        <person name="Jones S."/>
        <person name="Kagan R."/>
        <person name="King L.M."/>
        <person name="Leal B."/>
        <person name="Lebow H."/>
        <person name="Lee S."/>
        <person name="LeVan J.M."/>
        <person name="Lewis L.C."/>
        <person name="London P."/>
        <person name="Lorensuhewa L.M."/>
        <person name="Loulseged H."/>
        <person name="Lovett D.A."/>
        <person name="Lucier A."/>
        <person name="Lucier R.L."/>
        <person name="Ma J."/>
        <person name="Madu R.C."/>
        <person name="Mapua P."/>
        <person name="Martindale A.D."/>
        <person name="Martinez E."/>
        <person name="Massey E."/>
        <person name="Mawhiney S."/>
        <person name="Meador M.G."/>
        <person name="Mendez S."/>
        <person name="Mercado C."/>
        <person name="Mercado I.C."/>
        <person name="Merritt C.E."/>
        <person name="Miner Z.L."/>
        <person name="Minja E."/>
        <person name="Mitchell T."/>
        <person name="Mohabbat F."/>
        <person name="Mohabbat K."/>
        <person name="Montgomery B."/>
        <person name="Moore N."/>
        <person name="Morris S."/>
        <person name="Munidasa M."/>
        <person name="Ngo R.N."/>
        <person name="Nguyen N.B."/>
        <person name="Nickerson E."/>
        <person name="Nwaokelemeh O.O."/>
        <person name="Nwokenkwo S."/>
        <person name="Obregon M."/>
        <person name="Oguh M."/>
        <person name="Oragunye N."/>
        <person name="Oviedo R.J."/>
        <person name="Parish B.J."/>
        <person name="Parker D.N."/>
        <person name="Parrish J."/>
        <person name="Parks K.L."/>
        <person name="Paul H.A."/>
        <person name="Payton B.A."/>
        <person name="Perez A."/>
        <person name="Perrin W."/>
        <person name="Pickens A."/>
        <person name="Primus E.L."/>
        <person name="Pu L.-L."/>
        <person name="Puazo M."/>
        <person name="Quiles M.M."/>
        <person name="Quiroz J.B."/>
        <person name="Rabata D."/>
        <person name="Reeves K."/>
        <person name="Ruiz S.J."/>
        <person name="Shao H."/>
        <person name="Sisson I."/>
        <person name="Sonaike T."/>
        <person name="Sorelle R.P."/>
        <person name="Sutton A.E."/>
        <person name="Svatek A.F."/>
        <person name="Svetz L.A."/>
        <person name="Tamerisa K.S."/>
        <person name="Taylor T.R."/>
        <person name="Teague B."/>
        <person name="Thomas N."/>
        <person name="Thorn R.D."/>
        <person name="Trejos Z.Y."/>
        <person name="Trevino B.K."/>
        <person name="Ukegbu O.N."/>
        <person name="Urban J.B."/>
        <person name="Vasquez L.I."/>
        <person name="Vera V.A."/>
        <person name="Villasana D.M."/>
        <person name="Wang L."/>
        <person name="Ward-Moore S."/>
        <person name="Warren J.T."/>
        <person name="Wei X."/>
        <person name="White F."/>
        <person name="Williamson A.L."/>
        <person name="Wleczyk R."/>
        <person name="Wooden H.S."/>
        <person name="Wooden S.H."/>
        <person name="Yen J."/>
        <person name="Yoon L."/>
        <person name="Yoon V."/>
        <person name="Zorrilla S.E."/>
        <person name="Nelson D."/>
        <person name="Kucherlapati R."/>
        <person name="Weinstock G."/>
        <person name="Gibbs R.A."/>
      </authorList>
      <dbReference type="PubMed" id="16541075"/>
      <dbReference type="DOI" id="10.1038/nature04569"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="1999" name="EMBO J." volume="18" first="3688" last="3701">
      <title>A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription.</title>
      <authorList>
        <person name="Parada C.A."/>
        <person name="Roeder R.G."/>
      </authorList>
      <dbReference type="PubMed" id="10393184"/>
      <dbReference type="DOI" id="10.1093/emboj/18.13.3688"/>
    </citation>
    <scope>IDENTIFICATION IN A COMPLEX WITH HTATSF1; CDK9; RNA POL II; SUPT5H AND NCL</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1999" name="J. Mol. Biol." volume="288" first="41" last="56">
      <title>Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.</title>
      <authorList>
        <person name="Ivanov D."/>
        <person name="Kwak Y.T."/>
        <person name="Nee E."/>
        <person name="Guo J."/>
        <person name="Garcia-Martinez L.F."/>
        <person name="Gaynor R.B."/>
      </authorList>
      <dbReference type="PubMed" id="10329125"/>
      <dbReference type="DOI" id="10.1006/jmbi.1999.2663"/>
    </citation>
    <scope>INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION)</scope>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="1999" name="J. Mol. Biol." volume="288" first="57" last="69">
      <title>Role of the human and murine cyclin T proteins in regulating HIV-1 Tat-activation.</title>
      <authorList>
        <person name="Kwak Y.T."/>
        <person name="Ivanov D."/>
        <person name="Guo J."/>
        <person name="Nee E."/>
        <person name="Gaynor R.B."/>
      </authorList>
      <dbReference type="PubMed" id="10329126"/>
      <dbReference type="DOI" id="10.1006/jmbi.1999.2664"/>
    </citation>
    <scope>MUTAGENESIS OF CYS-261</scope>
    <scope>FUNCTION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="1998" name="Genes Dev." volume="12" first="3512" last="3527">
      <title>The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.</title>
      <authorList>
        <person name="Garber M.E."/>
        <person name="Wei P."/>
        <person name="KewalRamani V.N."/>
        <person name="Mayall T.P."/>
        <person name="Herrmann C.H."/>
        <person name="Rice A.P."/>
        <person name="Littman D.R."/>
        <person name="Jones K.A."/>
      </authorList>
      <dbReference type="PubMed" id="9832504"/>
      <dbReference type="DOI" id="10.1101/gad.12.22.3512"/>
    </citation>
    <scope>INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION)</scope>
    <scope>ROLE OF CYS-261</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="1999" name="J. Virol." volume="73" first="5777" last="5786">
      <title>Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.</title>
      <authorList>
        <person name="Bieniasz P.D."/>
        <person name="Grdina T.A."/>
        <person name="Bogerd H.P."/>
        <person name="Cullen B.R."/>
      </authorList>
      <dbReference type="PubMed" id="10364329"/>
      <dbReference type="DOI" id="10.1128/jvi.73.7.5777-5786.1999"/>
    </citation>
    <scope>INTERACTION WITH HIV-1 TAT; HIV-2 TAT AND SIV TAT (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="5897" last="5907">
      <title>Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.</title>
      <authorList>
        <person name="Fong Y.W."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="10913173"/>
      <dbReference type="DOI" id="10.1128/mcb.20.16.5897-5907.2000"/>
    </citation>
    <scope>INTERACTION WITH HTATSF1</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2002" name="J. Biomed. Sci." volume="9" first="234" last="245">
      <title>MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein.</title>
      <authorList>
        <person name="Estable M.C."/>
        <person name="Naghavi M.H."/>
        <person name="Kato H."/>
        <person name="Xiao H."/>
        <person name="Qin J."/>
        <person name="Vahlne A."/>
        <person name="Roeder R.G."/>
      </authorList>
      <dbReference type="PubMed" id="12065898"/>
      <dbReference type="DOI" id="10.1007/bf02256070"/>
    </citation>
    <scope>INTERACTION WITH AFF4</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="6373" last="6384">
      <title>The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription.</title>
      <authorList>
        <person name="Young T.M."/>
        <person name="Wang Q."/>
        <person name="Pe'ery T."/>
        <person name="Mathews M.B."/>
      </authorList>
      <dbReference type="PubMed" id="12944466"/>
      <dbReference type="DOI" id="10.1128/mcb.23.18.6373-6384.2003"/>
    </citation>
    <scope>INTERACTION WITH MDFIC</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2004" name="Virology" volume="318" first="306" last="317">
      <title>Evidence for conformational flexibility in the Tat-TAR recognition motif of cyclin T1.</title>
      <authorList>
        <person name="Das C."/>
        <person name="Edgcomb S.P."/>
        <person name="Peteranderl R."/>
        <person name="Chen L."/>
        <person name="Frankel A.D."/>
      </authorList>
      <dbReference type="PubMed" id="14972556"/>
      <dbReference type="DOI" id="10.1016/j.virol.2003.10.003"/>
    </citation>
    <scope>CHARACTERIZATION</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="523" last="534">
      <title>The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.</title>
      <authorList>
        <person name="Jang M.K."/>
        <person name="Mochizuki K."/>
        <person name="Zhou M."/>
        <person name="Jeong H.S."/>
        <person name="Brady J.N."/>
        <person name="Ozato K."/>
      </authorList>
      <dbReference type="PubMed" id="16109376"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2005.06.027"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH BRD4</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="535" last="545">
      <title>Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.</title>
      <authorList>
        <person name="Yang Z."/>
        <person name="Yik J.H."/>
        <person name="Chen R."/>
        <person name="He N."/>
        <person name="Jang M.K."/>
        <person name="Ozato K."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="16109377"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2005.06.029"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH BRD4</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="262" last="274">
      <title>Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.</title>
      <authorList>
        <person name="Jeronimo C."/>
        <person name="Forget D."/>
        <person name="Bouchard A."/>
        <person name="Li Q."/>
        <person name="Chua G."/>
        <person name="Poitras C."/>
        <person name="Therien C."/>
        <person name="Bergeron D."/>
        <person name="Bourassa S."/>
        <person name="Greenblatt J."/>
        <person name="Chabot B."/>
        <person name="Poirier G.G."/>
        <person name="Hughes T.R."/>
        <person name="Blanchette M."/>
        <person name="Price D.H."/>
        <person name="Coulombe B."/>
      </authorList>
      <dbReference type="PubMed" id="17643375"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2007.06.027"/>
    </citation>
    <scope>IDENTIFICATION IN THE 7SK SNRNP COMPLEX</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
      <title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
      <authorList>
        <person name="Daub H."/>
        <person name="Olsen J.V."/>
        <person name="Bairlein M."/>
        <person name="Gnad F."/>
        <person name="Oppermann F.S."/>
        <person name="Korner R."/>
        <person name="Greff Z."/>
        <person name="Keri G."/>
        <person name="Stemmann O."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="18691976"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495 AND SER-577</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
      <title>Large-scale proteomics analysis of the human kinome.</title>
      <authorList>
        <person name="Oppermann F.S."/>
        <person name="Gnad F."/>
        <person name="Olsen J.V."/>
        <person name="Hornberger R."/>
        <person name="Greff Z."/>
        <person name="Keri G."/>
        <person name="Mann M."/>
        <person name="Daub H."/>
      </authorList>
      <dbReference type="PubMed" id="19369195"/>
      <dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117 AND SER-340</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
      <title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
      <authorList>
        <person name="Choudhary C."/>
        <person name="Kumar C."/>
        <person name="Gnad F."/>
        <person name="Nielsen M.L."/>
        <person name="Rehman M."/>
        <person name="Walther T.C."/>
        <person name="Olsen J.V."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="19608861"/>
      <dbReference type="DOI" id="10.1126/science.1175371"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-390</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2013" name="Cell" volume="155" first="1581" last="1595">
      <title>Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release.</title>
      <authorList>
        <person name="Liu W."/>
        <person name="Ma Q."/>
        <person name="Wong K."/>
        <person name="Li W."/>
        <person name="Ohgi K."/>
        <person name="Zhang J."/>
        <person name="Aggarwal A."/>
        <person name="Rosenfeld M.G."/>
      </authorList>
      <dbReference type="PubMed" id="24360279"/>
      <dbReference type="DOI" id="10.1016/j.cell.2013.10.056"/>
    </citation>
    <scope>INTERACTION WITH BRD4 AND JMJD6</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340; SER-388; SER-564 AND SER-577</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2016" name="Cell Rep." volume="15" first="2756" last="2770">
      <title>T-bet activates Th1 genes through mediator and the super elongation complex.</title>
      <authorList>
        <person name="Hertweck A."/>
        <person name="Evans C.M."/>
        <person name="Eskandarpour M."/>
        <person name="Lau J.C."/>
        <person name="Oleinika K."/>
        <person name="Jackson I."/>
        <person name="Kelly A."/>
        <person name="Ambrose J."/>
        <person name="Adamson P."/>
        <person name="Cousins D.J."/>
        <person name="Lavender P."/>
        <person name="Calder V.L."/>
        <person name="Lord G.M."/>
        <person name="Jenner R.G."/>
      </authorList>
      <dbReference type="PubMed" id="27292648"/>
      <dbReference type="DOI" id="10.1016/j.celrep.2016.05.054"/>
    </citation>
    <scope>INTERACTION WITH TBX21</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="26294" last="26294">
      <title>Heat shock factor 1 mediates latent HIV reactivation.</title>
      <authorList>
        <person name="Pan X.Y."/>
        <person name="Zhao W."/>
        <person name="Zeng X.Y."/>
        <person name="Lin J."/>
        <person name="Li M.M."/>
        <person name="Shen X.T."/>
        <person name="Liu S.W."/>
      </authorList>
      <dbReference type="PubMed" id="27189267"/>
      <dbReference type="DOI" id="10.1038/srep26294"/>
    </citation>
    <scope>INTERACTION WITH HSF1</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
      <title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Lyon D."/>
        <person name="Young C."/>
        <person name="Jensen L.J."/>
        <person name="Vertegaal A.C."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="28112733"/>
      <dbReference type="DOI" id="10.1038/nsmb.3366"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-342; LYS-415 AND LYS-481</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2018" name="Cell Rep." volume="24" first="2141" last="2154">
      <title>Positive Regulation of Transcription by Human ZMYND8 through Its Association with P-TEFb Complex.</title>
      <authorList>
        <person name="Ghosh K."/>
        <person name="Tang M."/>
        <person name="Kumari N."/>
        <person name="Nandy A."/>
        <person name="Basu S."/>
        <person name="Mall D.P."/>
        <person name="Rai K."/>
        <person name="Biswas D."/>
      </authorList>
      <dbReference type="PubMed" id="30134174"/>
      <dbReference type="DOI" id="10.1016/j.celrep.2018.07.064"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH CDK9 AND ZMYND8</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2018" name="Nature" volume="558" first="318" last="323">
      <title>Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.</title>
      <authorList>
        <person name="Lu H."/>
        <person name="Yu D."/>
        <person name="Hansen A.S."/>
        <person name="Ganguly S."/>
        <person name="Liu R."/>
        <person name="Heckert A."/>
        <person name="Darzacq X."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="29849146"/>
      <dbReference type="DOI" id="10.1038/s41586-018-0174-3"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>DOMAIN</scope>
    <scope>MUTAGENESIS OF 517-HIS--LYS-527</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2021" name="Vaccines (Basel)" volume="9">
      <title>HSV-1 ICP22 Is a Selective Viral Repressor of Cellular RNA Polymerase II-Mediated Transcription Elongation.</title>
      <authorList>
        <person name="Isa N.F."/>
        <person name="Bensaude O."/>
        <person name="Aziz N.C."/>
        <person name="Murphy S."/>
      </authorList>
      <dbReference type="PubMed" id="34696162"/>
      <dbReference type="DOI" id="10.3390/vaccines9101054"/>
    </citation>
    <scope>INTERACTION WITH HHV-1 TRANSCRIPTIONAL REGULATOR ICP22 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2022" name="Nat. Cell Biol." volume="24" first="513" last="525">
      <title>Poly(ADP-ribosylation) of P-TEFb by PARP1 disrupts phase separation to inhibit global transcription after DNA damage.</title>
      <authorList>
        <person name="Fu H."/>
        <person name="Liu R."/>
        <person name="Jia Z."/>
        <person name="Li R."/>
        <person name="Zhu F."/>
        <person name="Zhu W."/>
        <person name="Shao Y."/>
        <person name="Jin Y."/>
        <person name="Xue Y."/>
        <person name="Huang J."/>
        <person name="Luo K."/>
        <person name="Gao X."/>
        <person name="Lu H."/>
        <person name="Zhou Q."/>
      </authorList>
      <dbReference type="PubMed" id="35393539"/>
      <dbReference type="DOI" id="10.1038/s41556-022-00872-5"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>ADP-RIBOSYLATION AT SER-416; SER-474; SER-475; LYS-485; HIS-487; HIS-530; SER-531; SER-549; HIS-556; SER-552; SER-563 AND SER-637</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2012" name="N. Engl. J. Med." volume="367" first="1921" last="1929">
      <title>Diagnostic exome sequencing in persons with severe intellectual disability.</title>
      <authorList>
        <person name="de Ligt J."/>
        <person name="Willemsen M.H."/>
        <person name="van Bon B.W."/>
        <person name="Kleefstra T."/>
        <person name="Yntema H.G."/>
        <person name="Kroes T."/>
        <person name="Vulto-van Silfhout A.T."/>
        <person name="Koolen D.A."/>
        <person name="de Vries P."/>
        <person name="Gilissen C."/>
        <person name="del Rosario M."/>
        <person name="Hoischen A."/>
        <person name="Scheffer H."/>
        <person name="de Vries B.B."/>
        <person name="Brunner H.G."/>
        <person name="Veltman J.A."/>
        <person name="Vissers L.E."/>
      </authorList>
      <dbReference type="PubMed" id="23033978"/>
      <dbReference type="DOI" id="10.1056/nejmoa1206524"/>
    </citation>
    <scope>VARIANT CYS-541</scope>
  </reference>
  <comment type="function">
    <text evidence="10 11 17 18 20">Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II) (PubMed:16109376, PubMed:16109377, PubMed:30134174, PubMed:35393539). Required to activate the protein kinase activity of CDK9: acts by mediating formation of liquid-liquid phase separation (LLPS) that enhances binding of P-TEFb to the CTD of RNA Pol II (PubMed:29849146, PubMed:35393539).</text>
  </comment>
  <comment type="function">
    <text evidence="3 4">(Microbial infection) In case of HIV or SIV infections, binds to the transactivation domain of the viral nuclear transcriptional activator, Tat, thereby increasing Tat's affinity for the transactivating response RNA element (TAR RNA). Serves as an essential cofactor for Tat, by promoting RNA Pol II activation, allowing transcription of viral genes.</text>
  </comment>
  <comment type="subunit">
    <text evidence="6 7 8 9 10 11 12 14 15 16 18 20 22">Cyclin-T1 is the predominant cyclin that associates with CDK9 to form a heterodimer called P-TEFb (PubMed:30134174, PubMed:35393539, PubMed:9499409). P-TEFb forms a complex with AFF4/AF5Q31 (PubMed:12065898). Component of a complex which is at least composed of HTATSF1/Tat-SF1, P-TEFb complex, RNA pol II, SUPT5H, and NCL/nucleolin (PubMed:10393184). Component of the 7SK snRNP complex at least composed of P-TEFb (composed of CDK9 and CCNT1/cyclin-T1), HEXIM1, HEXIM2, BCDIN3, SART3 proteins and 7SK and U6 snRNAs (PubMed:17643375). Interacts (via central region) with ZMYND8 (via N-terminus); the interaction is direct and the association appears to occur between homodimeric ZMYND8 and the activated form of the P-TEFb complex (PubMed:30134174). Interacts with BRD4, targets chromatin binding (PubMed:16109376, PubMed:16109377, PubMed:24360279). Interacts with JMJD6 (PubMed:24360279). Interacts with MDFIC (PubMed:12944466). Interacts with HSF1 (PubMed:27189267). Interacts with HTATSF1 (PubMed:10913173). Interacts with TBX21 (PubMed:27292648).</text>
  </comment>
  <comment type="subunit">
    <text evidence="3 4 5 21 23">(Microbial infection) Interacts with the transactivation region of HIV-1, HIV-2 and SIV Tat.</text>
  </comment>
  <comment type="subunit">
    <text evidence="19">(Microbial infection) Interacts with human herpes virus 1 (HHV-1) transcriptional regulator ICP22.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2479671">
      <id>O60563</id>
    </interactant>
    <interactant intactId="EBI-395282">
      <id>Q9UHB7</id>
      <label>AFF4</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>8</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2479671">
      <id>O60563</id>
    </interactant>
    <interactant intactId="EBI-9345088">
      <id>O60885-1</id>
      <label>BRD4</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2479671">
      <id>O60563</id>
    </interactant>
    <interactant intactId="EBI-1383449">
      <id>P50750</id>
      <label>CDK9</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>30</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2479671">
      <id>O60563</id>
    </interactant>
    <interactant intactId="EBI-2832510">
      <id>O94992</id>
      <label>HEXIM1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>13</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2479671">
      <id>O60563</id>
    </interactant>
    <interactant intactId="EBI-6164389">
      <id>P04608</id>
      <label>tat</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>9</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2479671">
      <id>O60563</id>
    </interactant>
    <interactant intactId="EBI-7845069">
      <id>P04610</id>
      <label>tat</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="9 17">Nucleus</location>
    </subcellularLocation>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>O60563-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>O60563-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_054569 VSP_054570"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="21 22">Ubiquitously expressed.</text>
  </comment>
  <comment type="domain">
    <text evidence="17">The histidine-rich domain (HRD) region is intrinsically disordered and promotes the formation of phase-separated liquid droplets that enhance binding of the P-TEFb complex to the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II).</text>
  </comment>
  <comment type="PTM">
    <text evidence="20">ADP-ribosylation on serine residues by PARP1 in response to DNA damage disrupts the phase separation activity of CCNT1, thereby preventing activation of CDK9.</text>
  </comment>
  <comment type="similarity">
    <text evidence="26">Belongs to the cyclin family. Cyclin C subfamily.</text>
  </comment>
  <dbReference type="EMBL" id="AF045161">
    <property type="protein sequence ID" value="AAC39638.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AF048730">
    <property type="protein sequence ID" value="AAC39664.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="EF688064">
    <property type="protein sequence ID" value="ABV58572.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC079951">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS61109.1">
    <molecule id="O60563-2"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS8766.1">
    <molecule id="O60563-1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001231.2">
    <molecule id="O60563-1"/>
    <property type="nucleotide sequence ID" value="NM_001240.3"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001264771.1">
    <molecule id="O60563-2"/>
    <property type="nucleotide sequence ID" value="NM_001277842.1"/>
  </dbReference>
  <dbReference type="PDB" id="2PK2">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.67 A"/>
    <property type="chains" value="A/B/C/D=1-281"/>
  </dbReference>
  <dbReference type="PDB" id="3BLH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.48 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="3BLQ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="3BLR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="3LQ5">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="3MI9">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="B=1-266"/>
  </dbReference>
  <dbReference type="PDB" id="3MIA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="B=1-266"/>
  </dbReference>
  <dbReference type="PDB" id="3MY1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="3TN8">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.95 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="3TNH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.20 A"/>
    <property type="chains" value="B=1-259"/>
  </dbReference>
  <dbReference type="PDB" id="3TNI">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.23 A"/>
    <property type="chains" value="B=1-259"/>
  </dbReference>
  <dbReference type="PDB" id="4BCF">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.01 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="4BCG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.08 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="4BCH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.96 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="4BCI">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="4BCJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.16 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="4EC8">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.60 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="4EC9">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.21 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="4IMY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.94 A"/>
    <property type="chains" value="B/D/F=1-264"/>
  </dbReference>
  <dbReference type="PDB" id="4OGR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.00 A"/>
    <property type="chains" value="B/F/K=1-264"/>
  </dbReference>
  <dbReference type="PDB" id="4OR5">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="B/G=1-266"/>
  </dbReference>
  <dbReference type="PDB" id="5L1Z">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="5.90 A"/>
    <property type="chains" value="B=1-264"/>
  </dbReference>
  <dbReference type="PDB" id="6CYT">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.50 A"/>
    <property type="chains" value="B=1-264"/>
  </dbReference>
  <dbReference type="PDB" id="6GZH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.17 A"/>
    <property type="chains" value="B=1-726"/>
  </dbReference>
  <dbReference type="PDB" id="6W9E">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="B=1-259"/>
  </dbReference>
  <dbReference type="PDB" id="6Z45">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.37 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="7NWK">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.81 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="8I0L">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.60 A"/>
    <property type="chains" value="B=2-259"/>
  </dbReference>
  <dbReference type="PDB" id="8K5R">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.75 A"/>
    <property type="chains" value="B=1-259"/>
  </dbReference>
  <dbReference type="PDBsum" id="2PK2"/>
  <dbReference type="PDBsum" id="3BLH"/>
  <dbReference type="PDBsum" id="3BLQ"/>
  <dbReference type="PDBsum" id="3BLR"/>
  <dbReference type="PDBsum" id="3LQ5"/>
  <dbReference type="PDBsum" id="3MI9"/>
  <dbReference type="PDBsum" id="3MIA"/>
  <dbReference type="PDBsum" id="3MY1"/>
  <dbReference type="PDBsum" id="3TN8"/>
  <dbReference type="PDBsum" id="3TNH"/>
  <dbReference type="PDBsum" id="3TNI"/>
  <dbReference type="PDBsum" id="4BCF"/>
  <dbReference type="PDBsum" id="4BCG"/>
  <dbReference type="PDBsum" id="4BCH"/>
  <dbReference type="PDBsum" id="4BCI"/>
  <dbReference type="PDBsum" id="4BCJ"/>
  <dbReference type="PDBsum" id="4EC8"/>
  <dbReference type="PDBsum" id="4EC9"/>
  <dbReference type="PDBsum" id="4IMY"/>
  <dbReference type="PDBsum" id="4OGR"/>
  <dbReference type="PDBsum" id="4OR5"/>
  <dbReference type="PDBsum" id="5L1Z"/>
  <dbReference type="PDBsum" id="6CYT"/>
  <dbReference type="PDBsum" id="6GZH"/>
  <dbReference type="PDBsum" id="6W9E"/>
  <dbReference type="PDBsum" id="6Z45"/>
  <dbReference type="PDBsum" id="7NWK"/>
  <dbReference type="PDBsum" id="8I0L"/>
  <dbReference type="PDBsum" id="8K5R"/>
  <dbReference type="AlphaFoldDB" id="O60563"/>
  <dbReference type="SMR" id="O60563"/>
  <dbReference type="BioGRID" id="107343">
    <property type="interactions" value="257"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-222">
    <property type="entry name" value="Positive transcription elongation factor B, CDK9-cyclinT1 complex"/>
  </dbReference>
  <dbReference type="CORUM" id="O60563"/>
  <dbReference type="DIP" id="DIP-29891N"/>
  <dbReference type="IntAct" id="O60563">
    <property type="interactions" value="116"/>
  </dbReference>
  <dbReference type="MINT" id="O60563"/>
  <dbReference type="STRING" id="9606.ENSP00000261900"/>
  <dbReference type="BindingDB" id="O60563"/>
  <dbReference type="ChEMBL" id="CHEMBL2108"/>
  <dbReference type="GlyGen" id="O60563">
    <property type="glycosylation" value="3 sites, 1 O-linked glycan (3 sites)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="O60563"/>
  <dbReference type="PhosphoSitePlus" id="O60563"/>
  <dbReference type="BioMuta" id="CCNT1"/>
  <dbReference type="CPTAC" id="CPTAC-2803"/>
  <dbReference type="jPOST" id="O60563"/>
  <dbReference type="MassIVE" id="O60563"/>
  <dbReference type="PaxDb" id="9606-ENSP00000261900"/>
  <dbReference type="PeptideAtlas" id="O60563"/>
  <dbReference type="ProteomicsDB" id="2517"/>
  <dbReference type="ProteomicsDB" id="49468">
    <molecule id="O60563-1"/>
  </dbReference>
  <dbReference type="Pumba" id="O60563"/>
  <dbReference type="ABCD" id="O60563">
    <property type="antibodies" value="6 sequenced antibodies"/>
  </dbReference>
  <dbReference type="Antibodypedia" id="1442">
    <property type="antibodies" value="326 antibodies from 38 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="904"/>
  <dbReference type="Ensembl" id="ENST00000261900.8">
    <molecule id="O60563-1"/>
    <property type="protein sequence ID" value="ENSP00000261900.3"/>
    <property type="gene ID" value="ENSG00000129315.12"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000417344.2">
    <molecule id="O60563-2"/>
    <property type="protein sequence ID" value="ENSP00000399845.2"/>
    <property type="gene ID" value="ENSG00000129315.12"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000618666.4">
    <molecule id="O60563-2"/>
    <property type="protein sequence ID" value="ENSP00000481035.1"/>
    <property type="gene ID" value="ENSG00000129315.12"/>
  </dbReference>
  <dbReference type="GeneID" id="904"/>
  <dbReference type="KEGG" id="hsa:904"/>
  <dbReference type="MANE-Select" id="ENST00000261900.8">
    <property type="protein sequence ID" value="ENSP00000261900.3"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_001240.4"/>
    <property type="RefSeq protein sequence ID" value="NP_001231.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001rsd.5">
    <molecule id="O60563-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:1599"/>
  <dbReference type="CTD" id="904"/>
  <dbReference type="DisGeNET" id="904"/>
  <dbReference type="GeneCards" id="CCNT1"/>
  <dbReference type="HGNC" id="HGNC:1599">
    <property type="gene designation" value="CCNT1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000129315">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MIM" id="143055">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_O60563"/>
  <dbReference type="OpenTargets" id="ENSG00000129315"/>
  <dbReference type="PharmGKB" id="PA26163"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000129315"/>
  <dbReference type="eggNOG" id="KOG0834">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000159544"/>
  <dbReference type="HOGENOM" id="CLU_022000_4_2_1"/>
  <dbReference type="InParanoid" id="O60563"/>
  <dbReference type="OMA" id="WAFANDS"/>
  <dbReference type="OrthoDB" id="4848076at2759"/>
  <dbReference type="PhylomeDB" id="O60563"/>
  <dbReference type="TreeFam" id="TF101014"/>
  <dbReference type="PathwayCommons" id="O60563"/>
  <dbReference type="Reactome" id="R-HSA-112382">
    <property type="pathway name" value="Formation of RNA Pol II elongation complex"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167152">
    <property type="pathway name" value="Formation of HIV elongation complex in the absence of HIV Tat"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167200">
    <property type="pathway name" value="Formation of HIV-1 elongation complex containing HIV-1 Tat"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167238">
    <property type="pathway name" value="Pausing and recovery of Tat-mediated HIV elongation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167243">
    <property type="pathway name" value="Tat-mediated HIV elongation arrest and recovery"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167246">
    <property type="pathway name" value="Tat-mediated elongation of the HIV-1 transcript"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167287">
    <property type="pathway name" value="HIV elongation arrest and recovery"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-167290">
    <property type="pathway name" value="Pausing and recovery of HIV elongation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-176034">
    <property type="pathway name" value="Interactions of Tat with host cellular proteins"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-2173796">
    <property type="pathway name" value="SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-674695">
    <property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-6796648">
    <property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-6807505">
    <property type="pathway name" value="RNA polymerase II transcribes snRNA genes"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-75955">
    <property type="pathway name" value="RNA Polymerase II Transcription Elongation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9018519">
    <property type="pathway name" value="Estrogen-dependent gene expression"/>
  </dbReference>
  <dbReference type="SignaLink" id="O60563"/>
  <dbReference type="SIGNOR" id="O60563"/>
  <dbReference type="BioGRID-ORCS" id="904">
    <property type="hits" value="39 hits in 1172 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="CCNT1">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="O60563"/>
  <dbReference type="GeneWiki" id="Cyclin_T1"/>
  <dbReference type="GenomeRNAi" id="904"/>
  <dbReference type="Pharos" id="O60563">
    <property type="development level" value="Tchem"/>
  </dbReference>
  <dbReference type="PRO" id="PR:O60563"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 12"/>
  </dbReference>
  <dbReference type="RNAct" id="O60563">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000129315">
    <property type="expression patterns" value="Expressed in sperm and 195 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="O60563">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008024">
    <property type="term" value="C:cyclin/CDK positive transcription elongation factor complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070691">
    <property type="term" value="C:P-TEFb complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0097322">
    <property type="term" value="F:7SK snRNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003682">
    <property type="term" value="F:chromatin binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0061575">
    <property type="term" value="F:cyclin-dependent protein serine/threonine kinase activator activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003677">
    <property type="term" value="F:DNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140297">
    <property type="term" value="F:DNA-binding transcription factor binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="ParkinsonsUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140693">
    <property type="term" value="F:molecular condensate scaffold activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0019901">
    <property type="term" value="F:protein kinase binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070063">
    <property type="term" value="F:RNA polymerase binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000976">
    <property type="term" value="F:transcription cis-regulatory region binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051301">
    <property type="term" value="P:cell division"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043923">
    <property type="term" value="P:positive regulation by host of viral transcription"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="ComplexPortal"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032786">
    <property type="term" value="P:positive regulation of DNA-templated transcription, elongation"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045944">
    <property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032968">
    <property type="term" value="P:positive regulation of transcription elongation by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000079">
    <property type="term" value="P:regulation of cyclin-dependent protein serine/threonine kinase activity"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006357">
    <property type="term" value="P:regulation of transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0009410">
    <property type="term" value="P:response to xenobiotic stimulus"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006366">
    <property type="term" value="P:transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="CDD" id="cd20595">
    <property type="entry name" value="CYCLIN_CCNT1_rpt1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd20597">
    <property type="entry name" value="CYCLIN_CCNT1_rpt2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="1.10.472.10">
    <property type="entry name" value="Cyclin-like"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR013763">
    <property type="entry name" value="Cyclin-like_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036915">
    <property type="entry name" value="Cyclin-like_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR043198">
    <property type="entry name" value="Cyclin/Ssn8"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR047320">
    <property type="entry name" value="CYCLIN_CCNT1_rpt2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR006671">
    <property type="entry name" value="Cyclin_N"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10026">
    <property type="entry name" value="CYCLIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10026:SF42">
    <property type="entry name" value="CYCLIN-T1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00134">
    <property type="entry name" value="Cyclin_N"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF21797">
    <property type="entry name" value="CycT2-like_C"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00385">
    <property type="entry name" value="CYCLIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF47954">
    <property type="entry name" value="Cyclin-like"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0013">ADP-ribosylation</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0131">Cell cycle</keyword>
  <keyword id="KW-0132">Cell division</keyword>
  <keyword id="KW-0175">Coiled coil</keyword>
  <keyword id="KW-0195">Cyclin</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0945">Host-virus interaction</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0804">Transcription</keyword>
  <keyword id="KW-0805">Transcription regulation</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="chain" id="PRO_0000080491" description="Cyclin-T1">
    <location>
      <begin position="1"/>
      <end position="726"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="2">
    <location>
      <begin position="360"/>
      <end position="385"/>
    </location>
  </feature>
  <feature type="region of interest" description="Histidine-rich domain (HRD)" evidence="17 20">
    <location>
      <begin position="480"/>
      <end position="550"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="17">
    <location>
      <begin position="487"/>
      <end position="650"/>
    </location>
  </feature>
  <feature type="region of interest" description="Required for interaction with ZMYND8" evidence="18">
    <location>
      <begin position="527"/>
      <end position="570"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="2">
    <location>
      <begin position="688"/>
      <end position="726"/>
    </location>
  </feature>
  <feature type="coiled-coil region" evidence="1">
    <location>
      <begin position="384"/>
      <end position="425"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal, and interaction with Tat-TAR RNA" evidence="27">
    <location>
      <begin position="253"/>
      <end position="270"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="2">
    <location>
      <begin position="487"/>
      <end position="505"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic residues" evidence="2">
    <location>
      <begin position="506"/>
      <end position="530"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="2">
    <location>
      <begin position="543"/>
      <end position="576"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Polar residues" evidence="2">
    <location>
      <begin position="592"/>
      <end position="633"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Pro residues" evidence="2">
    <location>
      <begin position="707"/>
      <end position="726"/>
    </location>
  </feature>
  <feature type="site" description="Essential for interacting with HIV-1 Tat">
    <location>
      <position position="261"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="29">
    <location>
      <position position="117"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="29 32">
    <location>
      <position position="340"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32">
    <location>
      <position position="388"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="30">
    <location>
      <position position="390"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="20">
    <location>
      <position position="416"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="20">
    <location>
      <position position="474"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="20">
    <location>
      <position position="475"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-(ADP-ribosyl)lysine" evidence="20">
    <location>
      <position position="485"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylhistidine" evidence="20">
    <location>
      <position position="487"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="28">
    <location>
      <position position="495"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="31">
    <location>
      <position position="499"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylhistidine" evidence="20">
    <location>
      <position position="530"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="20">
    <location>
      <position position="531"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="20">
    <location>
      <position position="549"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="20">
    <location>
      <position position="552"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylhistidine" evidence="20">
    <location>
      <position position="556"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="20">
    <location>
      <position position="563"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="32">
    <location>
      <position position="564"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="28 32">
    <location>
      <position position="577"/>
    </location>
  </feature>
  <feature type="modified residue" description="ADP-ribosylserine" evidence="20">
    <location>
      <position position="637"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="33">
    <location>
      <position position="342"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="33">
    <location>
      <position position="415"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="33">
    <location>
      <position position="481"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_054569" description="In isoform 2." evidence="25">
    <original>SLHL</original>
    <variation>RTDT</variation>
    <location>
      <begin position="181"/>
      <end position="184"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_054570" description="In isoform 2." evidence="25">
    <location>
      <begin position="185"/>
      <end position="726"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_053054" description="In dbSNP:rs17123261.">
    <original>H</original>
    <variation>R</variation>
    <location>
      <position position="362"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069400" description="In dbSNP:rs201951577." evidence="13">
    <original>R</original>
    <variation>C</variation>
    <location>
      <position position="541"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of HIV-1 Tat transactivation." evidence="4">
    <original>C</original>
    <variation>Y</variation>
    <location>
      <position position="261"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 9A; impaired formation of phase-separated liquid droplets, leading to decreased ability to activate CDK9." evidence="17">
    <original>HHHHHNHHSHK</original>
    <variation>AAAAANAASAKA</variation>
    <location>
      <begin position="517"/>
      <end position="527"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; AAC39664." evidence="26" ref="2">
    <original>Q</original>
    <variation>R</variation>
    <location>
      <position position="77"/>
    </location>
  </feature>
  <feature type="turn" evidence="36">
    <location>
      <begin position="8"/>
      <end position="12"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="16"/>
      <end position="20"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="25"/>
      <end position="27"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="31"/>
      <end position="52"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="56"/>
      <end position="69"/>
    </location>
  </feature>
  <feature type="turn" evidence="36">
    <location>
      <begin position="70"/>
      <end position="72"/>
    </location>
  </feature>
  <feature type="turn" evidence="36">
    <location>
      <begin position="75"/>
      <end position="77"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="80"/>
      <end position="94"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="101"/>
      <end position="112"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="114"/>
      <end position="116"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="124"/>
      <end position="143"/>
    </location>
  </feature>
  <feature type="turn" evidence="36">
    <location>
      <begin position="144"/>
      <end position="146"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="153"/>
      <end position="163"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="168"/>
      <end position="184"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="187"/>
      <end position="189"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="193"/>
      <end position="207"/>
    </location>
  </feature>
  <feature type="strand" evidence="34">
    <location>
      <begin position="216"/>
      <end position="218"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="221"/>
      <end position="224"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="231"/>
      <end position="246"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="249"/>
      <end position="251"/>
    </location>
  </feature>
  <feature type="helix" evidence="35">
    <location>
      <begin position="252"/>
      <end position="255"/>
    </location>
  </feature>
  <feature type="turn" evidence="34">
    <location>
      <begin position="258"/>
      <end position="262"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1"/>
  <evidence type="ECO:0000256" key="2">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="10329125"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="10329126"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="10364329"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="10393184"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="10913173"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="12065898"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="12944466"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="16109376"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="16109377"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="17643375"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="23033978"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="24360279"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="27189267"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="27292648"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="29849146"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="30134174"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="34696162"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="35393539"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="9491887"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="9499409"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="9832504"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="24">
    <source>
      <dbReference type="PubMed" id="35393539"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="25">
    <source ref="3"/>
  </evidence>
  <evidence type="ECO:0000305" key="26"/>
  <evidence type="ECO:0000305" key="27">
    <source>
      <dbReference type="PubMed" id="9491887"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="28">
    <source>
      <dbReference type="PubMed" id="18691976"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="29">
    <source>
      <dbReference type="PubMed" id="19369195"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="30">
    <source>
      <dbReference type="PubMed" id="19608861"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="31">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="32">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="33">
    <source>
      <dbReference type="PubMed" id="28112733"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="34">
    <source>
      <dbReference type="PDB" id="2PK2"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="35">
    <source>
      <dbReference type="PDB" id="3BLH"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="36">
    <source>
      <dbReference type="PDB" id="3MI9"/>
    </source>
  </evidence>
  <sequence length="726" mass="80685" checksum="4637EFB2DDEDFE13" modified="1998-08-01" version="1">MEGERKNNNKRWYFTREQLENSPSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYMIQSFTQFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYFMATNSLHLTTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHEFLQILEKTPNRLKRIWNWRACEAAKKTKADDRGTDEKTSEQTILNMISQSSSDTTIAGLMSMSTSTTSAVPSLPVSEESSSNLTSVEMLPGKRWLSSQPSFKLEPTQGHRTSENLALTGVDHSLPQDGSNAFISQKQNSKSVPSAKVSLKEYRAKHAEELAAQKRQLENMEANVKSQYAYAAQNLLSHHDSHSSVILKMPIEGSENPERPFLEKADKTALKMRIPVAGGDKAASSKPEEIKMRIKVHAAADKHNSVEDSVTKSREHKEKHKTHPSNHHHHHNHHSHKHSHSQLPVGTGNKRPGDPKHSSQTSNLAHKTYSLSSSFSSSSSTRKRGPSEETGGAVFDHPAKIAKSTKSSSLNFSFPSLPTMGQMPGHSSDTSGLSFSQPSCKTRVPHSKLDKGPTGANGHNTTQTIDYQDTVNMLHSLLSAQGVQPTQPTAFEFVRPYSDYLNPRSGGISSRSGNTDKPRPPPLPSEPPPPLPPLPK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>